First‐in‐human assessment of safety and pharmacokinetics of EP9001A:an anti‐nerve growth factor antibody for chronic pain treatment
用户UViUK3-Rlupw
1个月前
81
10
已完结
1. 系统已在2026-03-11 16:36:34对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1111/bph.70317
文献链接: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70317
其他信息:
出版社: Wiley
作者: Yue Cheng; Xiaohong Zhu; Ye Wang; Qingqing Li; Qiao Yan; Feiyan Zeng; Shuang Li; Siyu Li; Man Chen; Ping Feng
